TEVA - Teva- Pharmaceutical Industries Ltd ADR Options

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: TAK ZTS ABBV BMY PFE AZN NVS LLY MRK HLN

| Held by: IEFA EFA EIS EFG IXUS WCMI SPDW IDEV FNDF PPH

Scroll to Statements

Index	-	P/E	24.95	EPS (ttm)	1.35	Insider Own	0.01%	Shs Outstand	1.16B	Perf Week	2.28%
Market Cap	39.11B	Forward P/E	10.83	EPS next Y	3.10	Insider Trans	-95.68%	Shs Float	1.16B	Perf Month	-6.31%
Enterprise Value	52.28B	PEG	1.98	EPS next Q	0.60	Inst Own	61.87%	Short Float	2.91%	Perf Quarter	10.21%
Income	1.57B	P/S	2.23	EPS this Y	-23.03%	Inst Trans	-2.59%	Short Ratio	5.21	Perf Half Y	18.53%
Sales	17.53B	P/B	4.75	EPS next Y	37.49%	ROA	4.01%	Short Interest	33.87M	Perf YTD	7.59%
Book/sh	7.07	P/C	10.45	EPS next 5Y	5.46%	ROE	21.73%	52W High	37.35 -10.08%	Perf Year	90.90%
Cash/sh	3.21	P/FCF	88.05	EPS past 3/5Y	- -	ROIC	6.99%	52W Low	14.99 124.02%	Perf 3Y	358.12%
Dividend Est.	-	EV/EBITDA	10.30	Sales past 3/5Y	5.53% 0.80%	Gross Margin	52.19%	Volatility	3.95% 2.99%	Perf 5Y	191.24%
Dividend TTM	-	EV/Sales	2.98	EPS Y/Y TTM	220.46%	Oper. Margin	23.22%	ATR (14)	1.17	Perf 10Y	-36.65%
Dividend Ex-Date	Nov 27, 2017	Quick Ratio	0.78	Sales Y/Y TTM	5.76%	Profit Margin	8.98%	RSI (14)	47.55	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	1.01	EPS Q/Q	69.90%	SMA20	-2.09%	Beta	0.86	Target Price	42.11
Payout	0.00%	Debt/Eq	2.05	Sales Q/Q	3.60%	SMA50	1.04%	Rel Volume	0.59	Prev Close	34.45
Employees	33346	LT Debt/Eq	1.74	Earnings	Apr 29 BMO	SMA200	18.63%	Avg Volume	6.50M	Price	33.58
IPO	Feb 16, 1982	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.53% 5.14%	Trades		Volume	3,850,467	Change	-2.53%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)